Ludmila Penido
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ludmila Penido has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Luana Campos
Graduate Program in Implantology, University of Santo Amaro, São Paulo, SP, Brazil
1 shared publication - Luiz Felipe Palma
Department of Pathology, Federal University of São Paulo, São Paulo, SP, Brazil
1 shared publication - Luís Otávio Carvalho de Moraes
Discipline of Descriptive and Topographic Anatomy, Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, SP, Brazil
1 shared publication - Sandro Francisco de Oliveira
Graduate Dentistry Program, Ibirapuera University, São Paulo, SP, Brazil
1 shared publication - Susana Morimoto
Universidade Ibirapuera, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 14, e4
Photobiomodulation Therapy for Multiple Painful Fixed Drug Eruptions: The First Case Report
Introduction: Fixed drug eruption (FDE), a very specific adverse drug reaction and one of the most common types of drug eruption, generally resolves spontaneously within 7-10 days upon withdrawal of the causative agent; however, extensive and severe cases may also require systemic drug therapy. The present study aimed to report a case in which a broad spectrum of severe, painful lesions of FDE was managed with photobiomodulation therapy (PBMT). Case Report:A 31-year-old Caucasian woman presented with many extremely painful mucocutaneous lesions of FDE which had arisen 8 days before, following a long period of hospitalization. The lesions were not responsive to either corticosteroids or analgesics within 5 days, and then seven daily sessions of PBMT were proposed. Pain alleviation was achieved on the 1st day of PBMT, and the lesions showed an advanced course of healing on the 3rd day. Within 7 days of PBMT, the lesions were almost completely repaired. In a 3-month follow-up period, no relapse of any FDE lesion was reported. Conclusion: PBMT may be a promising strategy for the management of painful lesions of FDE refractory to conventional medication therapy. However, further studies are needed to confirm this hypothesis.
- 1 January 2023
- Published by Maad Rayan Publishing Company in Journal of lasers in medical sciences
- Vol. 14, e4
Open AccessPhotobiomodulation Therapy for Multiple Painful Fixed Drug Eruptions: The First Case Report
Introduction: Fixed drug eruption (FDE), a very specific adverse drug reaction and one of the most common types of drug eruption, generally resolves spontaneously within 7-10 days upon withdrawal of the causative agent; however, extensive and severe cases may also require systemic drug therapy. The present study aimed to report a case in which a broad spectrum of severe, painful lesions of FDE was managed with photobiomodulation therapy (PBMT). Case Report:A 31-year-old Caucasian woman presented with many extremely painful mucocutaneous lesions of FDE which had arisen 8 days before, following a long period of hospitalization. The lesions were not responsive to either corticosteroids or analgesics within 5 days, and then seven daily sessions of PBMT were proposed. Pain alleviation was achieved on the 1st day of PBMT, and the lesions showed an advanced course of healing on the 3rd day. Within 7 days of PBMT, the lesions were almost completely repaired. In a 3-month follow-up period, no relapse of any FDE lesion was reported. Conclusion: PBMT may be a promising strategy for the management of painful lesions of FDE refractory to conventional medication therapy. However, further studies are needed to confirm this hypothesis.